Paras Biomultifold® Technology

Biomultifold® provides an innovative and highly efficient process for the production of recombinant proteins using an E. Coli expression system. Biomultifold® enables to achieve expression levels of multigrams of therapeutic proteins per liter of fermentation. This facilitates a very economical and cost effective system for manufacturing of recombinant proteins and their scale up production. Biomultifold® is therefore, the most suitable technology for the large scale production of Biosimilars and therapeutic products at the commercial scale.

Focused Approach

Paras Biopharmaceuticals Finland Oy approach is to produce high quality Biosimilars and long therapeutic peptides in most economical manner. The company utilizes the strong scientific expertise and industrial experience of its team to achieve highest production of biologics at scale up level.

Economical Multiple Inducer

One of the most advanced features of Biomultifold® E. Coli based technology is achieving high biomass and production with a very economical multiple inducer. The proven Biomultifold® technology comprises of a tightly regulated expression system induced by a low cost, non toxic propriety inducer. As the inducer is completely non-toxic, it leads to simplified post production phase of protein purification, also significantly bringing done the purification costs.

Economical Multiple Inducer

Biomultifold®- Technology Spotlight

Company Presentation 2018

Company Presentation 2016

Company Presentation 2014

Company Presentation 2012

Meet Us At

Connect with us

Paras Biopharmaceuticals
Finland Oy
,

Kiviharjunlenkki 10, OULU,
FI-90220 Finland

P: +358 442709462

Dr Ashesh Kumar
E: kumar.ashesh@parasbiopharma.com
P: +358 (0) 400207380

Dr Upendra Khurana
E: upendra.khurana@parasbiopharma.com
P:+358 (0) 449783160

Dr Mark Jackson
E: mark.jackson@parasbiopharma.com
P:+358 (0) 442905993

Skype: Paras.Finland